Loading data
CLBTNasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 475.68 m USD | 401.2 m USD | 325.11 m USD | 270.65 m USD | 246.25 m USD |
| Cost of revenue | 75.17 m USD | 62.59 m USD | 53.23 m USD | 50.75 m USD | 42.56 m USD |
| Gross profit | 400.5 m USD | 338.61 m USD | 271.88 m USD | 219.91 m USD | 203.69 m USD |
| Research and development expense | 113.88 m USD | 98.42 m USD | 84.39 m USD | 80.62 m USD | 65.54 m USD |
| Operating profit | 66.48 m USD | 56.91 m USD | 33.24 m USD | 1.04 m USD | 13.82 m USD |
| Profit before tax | 90.68 m USD | -275.98 m USD | -75.56 m USD | 120.76 m USD | 82.31 m USD |
| Income tax expense | 12.35 m USD | 7.02 m USD | 5.54 m USD | -45 k USD | 10.91 m USD |
| Net income (reported basis) | 78.33 m USD | -283.01 m USD | -81.1 m USD | 120.81 m USD | 71.4 m USD |
| Net income attributable to common shareholders | 77.81 m USD | -283.01 m USD | -81.1 m USD | 116.11 m USD | 70.43 m USD |
| Basic earnings per share | 0.32 USD/share | -1.35 USD/share | -0.43 USD/share | 0.64 USD/share | 0.49 USD/share |
| Diluted earnings per share | 0.31 USD/share | -1.35 USD/share | -0.43 USD/share | 0.59 USD/share | 0.44 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.